Clonazepam

Product NDC: 0378-1910
11-digit product format: 003781910
Labeler code: 0378
Product ID: 0378-1910_78a9d4a8-6039-4022-bf34-5e44ef2757af
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: clonazepam
Dosage form: TABLET
Route: ORAL
Labeler: Mylan Pharmaceuticals Inc.
Application: ANDA075150
Marketing category: ANDA
Marketing start: 1998-10-20
Marketing end: 2020-04-30
Substance: CLONAZEPAM
Active strength: 1 mg/1
Pharmacologic classes: Benzodiazepine [EPC],Benzodiazepines [CS]
DEA schedule: CIV
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	0378-1910		D	Discontinued by firm	2026-08-17
excluded package	package	0378-1910	0378-1910-01	D	Discontinued by firm	2026-08-17
excluded package	package	0378-1910	0378-1910-10	D	Discontinued by firm	2026-08-17
excluded package	package	0378-1910	0378-1910-77	D	Discontinued by firm	2026-08-17

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0378-1910-77	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0378-1910-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0378-1910-10	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0378-1910-77	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0378-1910-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0378-1910-10	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0378-1910-77	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0378-1910-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0378-1910-10	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0378-1910-77	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0378-1910-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0378-1910-10	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0378-1910-77	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0378-1910-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0378-1910-10	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0378-1910-77	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0378-1910-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0378-1910-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0378-1910-77	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0378-1910-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0378-1910-10	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0378-1910-77	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0378-1910-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0378-1910-10	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0378-1910-77	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0378-1910-01	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0378-1910-10	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0378-1910-77	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0378-1910-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0378-1910-10	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0378-1910-77	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0378-1910-01	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0378-1910-10	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0378-1910-77	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0378-1910-01	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0378-1910-10	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A075150-001	CLONAZEPAM	CLONAZEPAM	0.5MG	TABLET / ORAL	AB	1998-10-05
A075150-002	CLONAZEPAM	CLONAZEPAM	1MG	TABLET / ORAL	AB	1998-10-05
A075150-003	CLONAZEPAM	CLONAZEPAM	2MG	TABLET / ORAL	AB	1998-10-05

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A075150-001	AB
A075150-002	AB
A075150-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A075150-001	CLONAZEPAM	0.5MG	TABLET / ORAL	AB	1998-10-05	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075150-002	CLONAZEPAM	1MG	TABLET / ORAL	AB	1998-10-05	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075150-003	CLONAZEPAM	2MG	TABLET / ORAL	AB	1998-10-05	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A075150-001	CLONAZEPAM	0.5MG	TABLET / ORAL	AB	1998-10-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075150-002	CLONAZEPAM	1MG	TABLET / ORAL	AB	1998-10-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075150-003	CLONAZEPAM	2MG	TABLET / ORAL	AB	1998-10-05	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075150-001	CLONAZEPAM	0.5MG	TABLET / ORAL	AB	1998-10-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075150-002	CLONAZEPAM	1MG	TABLET / ORAL	AB	1998-10-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075150-003	CLONAZEPAM	2MG	TABLET / ORAL	AB	1998-10-05	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075150-001	CLONAZEPAM	0.5MG	TABLET / ORAL	AB	1998-10-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075150-002	CLONAZEPAM	1MG	TABLET / ORAL	AB	1998-10-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075150-003	CLONAZEPAM	2MG	TABLET / ORAL	AB	1998-10-05	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075150-001	CLONAZEPAM	0.5MG	TABLET / ORAL	AB	1998-10-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075150-002	CLONAZEPAM	1MG	TABLET / ORAL	AB	1998-10-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075150-003	CLONAZEPAM	2MG	TABLET / ORAL	AB	1998-10-05	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075150-001	CLONAZEPAM	0.5MG	TABLET / ORAL	AB	1998-10-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075150-002	CLONAZEPAM	1MG	TABLET / ORAL	AB	1998-10-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075150-003	CLONAZEPAM	2MG	TABLET / ORAL	AB	1998-10-05	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075150-001	CLONAZEPAM	0.5MG	TABLET / ORAL	AB	1998-10-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075150-002	CLONAZEPAM	1MG	TABLET / ORAL	AB	1998-10-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075150-003	CLONAZEPAM	2MG	TABLET / ORAL	AB	1998-10-05	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075150-001	CLONAZEPAM	0.5MG	TABLET / ORAL	AB	1998-10-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075150-002	CLONAZEPAM	1MG	TABLET / ORAL	AB	1998-10-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075150-003	CLONAZEPAM	2MG	TABLET / ORAL	AB	1998-10-05	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075150-001	CLONAZEPAM	0.5MG	TABLET / ORAL	AB	1998-10-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075150-002	CLONAZEPAM	1MG	TABLET / ORAL	AB	1998-10-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075150-003	CLONAZEPAM	2MG	TABLET / ORAL	AB	1998-10-05	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075150-001	CLONAZEPAM	0.5MG	TABLET / ORAL	AB	1998-10-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075150-002	CLONAZEPAM	1MG	TABLET / ORAL	AB	1998-10-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075150-003	CLONAZEPAM	2MG	TABLET / ORAL	AB	1998-10-05	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075150-001	CLONAZEPAM	0.5MG	TABLET / ORAL	AB	1998-10-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075150-002	CLONAZEPAM	1MG	TABLET / ORAL	AB	1998-10-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075150-003	CLONAZEPAM	2MG	TABLET / ORAL	AB	1998-10-05	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075150-001	CLONAZEPAM	0.5MG	TABLET / ORAL	AB	1998-10-05	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075150-002	CLONAZEPAM	1MG	TABLET / ORAL	AB	1998-10-05	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075150-003	CLONAZEPAM	2MG	TABLET / ORAL	AB	1998-10-05	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075150-001	CLONAZEPAM	0.5MG	TABLET / ORAL	AB	1998-10-05	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075150-002	CLONAZEPAM	1MG	TABLET / ORAL	AB	1998-10-05	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075150-003	CLONAZEPAM	2MG	TABLET / ORAL	AB	1998-10-05	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075150-001	CLONAZEPAM	0.5MG	TABLET / ORAL	AB	1998-10-05	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 84 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A075150-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075150-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A075150-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A075150-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075150-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A075150-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075150-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075150-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075150-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075150-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075150-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A075150-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075150-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075150-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075150-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075150-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075150-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075150-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075150-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075150-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075150-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075150-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075150-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075150-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075150-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075150-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075150-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075150-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075150-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075150-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075150-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075150-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A075150-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075150-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075150-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075150-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075150-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075150-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075150-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075150-001	AB	1	`1e350fbaab3a…`

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0378-1910-01	EA - Each	0378-1910	37bffebe-f90a-4860-a8ce-97320f167273	1	2012-07-24
0378-1910-10	EA - Each	0378-1910	386dabf3-d78e-4408-a0b6-7e63a0ca9494	1	2012-07-24
0378-1910-77	EA - Each	0378-1910	8bbc4c63-7176-4feb-b4c3-678405087edb	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CLONAZEPAM	ACTIVE INGREDIENT	5PE9FDE8GB	CLONAZEPAM TABLET [MYLAN PHARMACEUTICALS INC.]	5
CLONAZEPAM	ACTIVE MOIETY	5PE9FDE8GB	CLONAZEPAM TABLET [MYLAN PHARMACEUTICALS INC.]	5
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	CLONAZEPAM TABLET [MYLAN PHARMACEUTICALS INC.]	5
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CLONAZEPAM TABLET [MYLAN PHARMACEUTICALS INC.]	5
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CLONAZEPAM TABLET [MYLAN PHARMACEUTICALS INC.]	5
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CLONAZEPAM TABLET [MYLAN PHARMACEUTICALS INC.]	5
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CLONAZEPAM TABLET [MYLAN PHARMACEUTICALS INC.]	5
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CLONAZEPAM TABLET [MYLAN PHARMACEUTICALS INC.]	5
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CLONAZEPAM TABLET [MYLAN PHARMACEUTICALS INC.]	5
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	CLONAZEPAM TABLET [MYLAN PHARMACEUTICALS INC.]	5
CLONAZEPAM	ACTIVE INGREDIENT	5PE9FDE8GB	CLONAZEPAM TABLET [MYLAN INSTITUTIONAL INC.]	4
CLONAZEPAM	ACTIVE MOIETY	5PE9FDE8GB	CLONAZEPAM TABLET [MYLAN INSTITUTIONAL INC.]	4
ANHYDROUS LACTOSE	INACTIVE INGREDIENT	3SY5LH9PMK	CLONAZEPAM TABLET [MYLAN INSTITUTIONAL INC.]	4
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	CLONAZEPAM TABLET [MYLAN INSTITUTIONAL INC.]	4
D&C YELLOW NO. 10	INACTIVE INGREDIENT	35SW5USQ3G	CLONAZEPAM TABLET [MYLAN INSTITUTIONAL INC.]	4
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	CLONAZEPAM TABLET [MYLAN INSTITUTIONAL INC.]	4
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	CLONAZEPAM TABLET [MYLAN INSTITUTIONAL INC.]	4
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	CLONAZEPAM TABLET [MYLAN INSTITUTIONAL INC.]	4
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	CLONAZEPAM TABLET [MYLAN INSTITUTIONAL INC.]	4
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	CLONAZEPAM TABLET [MYLAN INSTITUTIONAL INC.]	4

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 9 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Clonazepam	CLONAZEPAM	REMEDYREPACK INC.	1fb0807c-dccd-47a5-ada4-91418c4f47f5	2026-06-11	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075150 application number: ANDA075150
Clonazepam	CLONAZEPAM	REMEDYREPACK INC.	f613573a-3e8b-4abf-af69-0268f3d6f481	2026-06-09	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075150 application number: ANDA075150
Clonazepam	CLONAZEPAM	REMEDYREPACK INC.	2606ecf9-3d71-4c1c-bfda-d7d98ffc6011	2026-03-09	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075150 application number: ANDA075150
Clonazepam	CLONAZEPAM	Proficient Rx LP	44f39aa8-a7bc-4e42-977c-31583e6388ae	2026-03-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075150 application number: ANDA075150
Clonazepam	CLONAZEPAM	Bryant Ranch Prepack	dec8b5b2-2490-4880-a8d1-707b57954297	2025-06-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075150 application number: ANDA075150
Clonazepam	CLONAZEPAM	Aphena Pharma Solutions - Tennessee, LLC	214e760b-c909-bd93-e063-6294a90ae74a	2024-10-22	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075150 application number: ANDA075150
Clonazepam	CLONAZEPAM	Aphena Pharma Solutions - Tennessee, LLC	20b3125e-4489-3c53-e063-6294a90a6539	2024-08-27	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075150 application number: ANDA075150
Clonazepam	CLONAZEPAM	Advanced Rx Pharmacy of Tennessee, LLC	04db0fbe-7fa3-28af-e063-6294a90abbe6	2024-06-07	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075150 application number: ANDA075150
Clonazepam	CLONAZEPAM	Aurobindo Pharma Limited	b1582eb7-af35-45d5-a52e-0e380d08527d	2023-02-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075150 application number: ANDA075150

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
5PE9FDE8GB	CLONAZEPAM	1622-61-3	CLONAZEPAM

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Clonazepam - Mylan Institutional Inc.	Mylan Institutional Inc.	2018-12-26	HUMAN PRESCRIPTION DRUG LABEL	8
Clonazepam - Mylan Pharmaceuticals Inc.	Mylan Pharmaceuticals Inc.	2018-05-24	HUMAN PRESCRIPTION DRUG LABEL	11